Evropska unija - slovenščina - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateron acetat - prostatične neoplazme - endokrini terapija - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

mylan ireland limited - abirateron acetat - prostatične neoplazme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of adult patients with prostate cancer.

Evropska unija - slovenščina - EMA (European Medicines Agency)

gedeon richter plc. - ulipristal acetat - leiomyoma - spolni hormoni in zdravila genitalni sistem, - ulipristal acetata, ki je navedena za eno zdravljenje, seveda pre-operative zdravljenje zmerne do hude simptome maternice fibroids v odrasle ženske v rodni dobi. ulipristal acetata je primerna za občasno zdravljenje zmerne do hude simptome maternice fibroids v izobraževanje žensk v rodni dobi, ki niso primerni za operacijo.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenis d.o.o. - hidroksokobalaminijev acetat - raztopina za injiciranje - hidroksokobalaminijev acetat 10 mg / 2 ml - hidroksokobalamin

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lenis d.o.o. - raztopina za injiciranje - hidroksokobalamin

Evropska unija - slovenščina - EMA (European Medicines Agency)

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hipofize in hipotalamični hormoni in analogi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

krka, d.d., novo mesto - vseracemni-alfa-tokoferilacetat - obložena tableta - vseracemni-alfa-tokoferilacetat 100 mg / 1 tableta - tokoferol (vitamin e)

Evropska unija - slovenščina - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - atosiban (as acetate) - predčasno rojstvo - drugi gynecologicals - atosiban je navedeno, da odloži neposredno pred rokom rodila pri nosečnicah odrasle ženske z:redni kontrakcije maternice najmanj 30 sekund trajanje na hitrost ≥ 4 na 30 minut;materničnega vratu dilatacija 1 do 3 cm (0-3 za nulliparas) in effacement ≥ 50%;gestacijske starosti od 24 do 33 končana tednov;običajno plod srčni utrip.

Evropska unija - slovenščina - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimikotiki za sistemsko uporabo - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.